Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06KYU
|
|||
| Former ID |
DIB003458
|
|||
| Drug Name |
Rycals
|
|||
| Synonyms |
Rycals (cardiac disease/muscle disorders); Calcium release channel stabilizers (cardiac disease/muscle disorders), Armgo; Rycals (cardiac disease/muscle disorders), Armgo
Click to Show/Hide
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Preclinical | [1] | |
| Company |
Columbia University
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calcium channel unspecific (CaC) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030217) | |||
| REF 2 | Fixing ryanodine receptor Ca2+ leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discov Today Dis Mech. 2010 SUMMER; 7(2): e151-e157. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.